Page last updated: 2024-10-22

amoxapine and Stevens-Johnson Syndrome

amoxapine has been researched along with Stevens-Johnson Syndrome in 1 studies

Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camisa, C1
Grines, C1

Other Studies

1 other study available for amoxapine and Stevens-Johnson Syndrome

ArticleYear
Amoxapine: a cause of toxic epidermal necrolysis?
    Archives of dermatology, 1983, Volume: 119, Issue:9

    Topics: Amoxapine; Dibenzoxazepines; Female; Humans; Middle Aged; Stevens-Johnson Syndrome

1983